Page last updated: 2024-11-02

pioglitazone and Intertrochanteric Fractures

pioglitazone has been researched along with Intertrochanteric Fractures in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colhoun, HM1
Livingstone, SJ1
Looker, HC1
Morris, AD1
Wild, SH1
Lindsay, RS1
Reed, C1
Donnan, PT1
Guthrie, B1
Leese, GP1
McKnight, J1
Pearson, DW1
Pearson, E1
Petrie, JR1
Philip, S1
Sattar, N1
Sullivan, FM1
McKeigue, P1

Other Studies

1 other study available for pioglitazone and Intertrochanteric Fractures

ArticleYear
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs.
    Diabetologia, 2012, Volume: 55, Issue:11

    Topics: Age Distribution; Aged; Databases, Factual; Diabetes Mellitus, Type 2; Drug Prescriptions; Female; F

2012